Squarepoint
EW icon

Squarepoint’s Edwards Lifesciences EW Stock Holding History

Squarepoint’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,600
Closed -$202K – 4438
2025
Q3 		$202K Buy
+2,600
New +$203K ﹤0.01% 3935
2025
Q2 		– Sell
-2,800
Closed -$203K – 4644
2025
Q1 		$203K Sell
2,800
-18,700
-87% -$1.34M ﹤0.01% 4010
2024
Q4 		$1.59M Sell
21,500
-58,000
-73% -$4.06M ﹤0.01% 2625
2024
Q3 		$5.25M Buy
79,500
+74,900
+1,628% +$5.44M 0.01% 1386
2024
Q2 		$425K Sell
4,600
-134,400
-97% -$11.9M ﹤0.01% 3200
2024
Q1 		$13.3M Buy
+139,000
New +$11.7M 0.02% 834
2023
Q4 		– Sell
-3,900
Closed -$270K – 4124
2023
Q3 		$270K Sell
3,900
-8,200
-68% -$659K ﹤0.01% 3243
2023
Q2 		$1.14M Buy
+12,100
New +$1.05M ﹤0.01% 2064
2022
Q1 		– Sell
-15,900
Closed -$2.06M – 3031
2021
Q4 		$2.06M Sell
15,900
-1,600
-9% -$187K 0.01% 1239
2021
Q3 		$1.98M Buy
17,500
+1,600
+10% +$183K 0.01% 1207
2021
Q2 		$1.65M Hold
15,900
– – 0.01% 1307
2021
Q1 		$1.33M Buy
15,900
+7,500
+89% +$634K 0.01% 1308
2020
Q4 		$766K Buy
+8,400
New +$697K 0.01% 1498

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Squarepoint's EW Position: Q1 2026 in Review

Squarepoint reduced its Edwards Lifesciences (EW) stake by 0.25% in Q1 2026, selling an estimated $3.21K and leaving 15,426 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2595.

Squarepoint first reported a position in EW in Q4 2014 and has held it in 36 quarters since. The position peaked at $65.2M in Q4 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Squarepoint held 15,426 shares of Edwards Lifesciences worth $1.24M as of Q1 2026.
  • Squarepoint sold 39 Edwards Lifesciences shares in Q1 2026, an estimated $3.21K.
  • Edwards Lifesciences made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2595 holding.
  • Squarepoint first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 36 quarters since.
  • Squarepoint's Edwards Lifesciences position peaked at $65.2M in Q4 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.